Isomorphic Labs raises $2.1 billion Series B
Isomorphic Labs raised $2.1 billion in a Series B round led by Thrive Capital. Existing investors Alphabet and GV participated with new backers MGX, Temasek, CapitalG, and the UK Sovereign AI Fund. The capital expands the company's AI drug design platform across small molecules, antibodies, and RNA therapeutics while extending earlier AlphaFold protein structure work. Founder Demis Hassabis announced the round on X.
I’ve always believed the No.1 application of AI should be to improve human health.
That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease!
We are turbocharging that goal with $2.1B in new funding.
Read more here: http://bit.ly/4v2OI03
I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.
Congrats
I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.
It’s amazing to see what happens when technology actually works. When AI research breakthroughs lead to new models that can be creatively used by drug designers through ridiculously scalable inference infrastructure and result in new scientific progress measured in the real world
Huge news today at Isomorphic Labs! We have secured $2.1 Billion investment to advance the most important mission that AI can unlock: to change the way we can improve human health and create new medicines for patients around the world. This funding milestone was built on the strength of our AI drug design engine (IsoDDE), which has already proven its worth (aside from smashing benchmarks) by designing breakthrough new molecules and creating new scientific breakthroughs across our drug discovery programs. Our IsoDDE is giving us a repeatable way to design new medicines for a wide range of diseases, building a future of medicine that we couldn’t unlock until now. A massive thank you to our incredible team across London, Boston and Lausanne, whose relentless work made this possible, and to our partners who share our ultimate vision. Now we have so much more to build together!
Huge news today at Isomorphic Labs!
We have secured $2.1 Billion investment to advance the most important mission that AI can unlock: to change the way we can improve human health and create new medicines for patients around the world.
This funding milestone was built on the strength of our AI drug design engine (IsoDDE), which has already proven its worth (aside from smashing benchmarks) by designing breakthrough new molecules and creating new scientific breakthroughs across our drug discovery programs.
Our IsoDDE is giving us a repeatable way to design new medicines for a wide range of diseases, building a future of medicine that we couldn’t unlock until now.
A massive thank you to our incredible team across London, Boston and Lausanne, whose relentless work made this possible, and to our partners who share our ultimate vision.
Now we have so much more to build together!
Announcement from Sir Demis's Isomorphic Labs.
I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.
Tired: replacing humans Wired: healing humans
I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.
@JoshuaKushner @andrewarruda More bets like this please
at a moment when so much of the discourse around technological progress centers on the risks it may create, this mission offers a glimpse of what the future could look like if humanity gets it right
at a moment when so much of the discourse around technological progress centers on the risks it may create, this mission offers a glimpse of what the future could look like if humanity gets it right
I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.
SovAI racking up an impressive portfolio!
I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.